Are Tanning Peptides Safe? Melanotan II Risks and the One Approved Exception
No. Melanotan II is unapproved and unregulated, and dermatologists have documented eruptive moles and melanoma in users; the only approved melanocortin peptide, afamelanotide, treats a rare light-sensitivity disorder, not cosmetic tanning.
Key takeaways
- Melanotan II is not FDA-approved, is illegal to sell for human use in many countries, and is sold online with no guarantee of identity, purity or dose.[1]
- A single dose has produced eruptive new moles and darkening of existing moles within 24 hours, and melanoma in situ has been reported in a user.[3][4]
- Melanocortin peptides act on receptors beyond the skin, so nausea, flushing, spontaneous erections and blood-pressure changes are common.[1]
- The only approved melanocortin peptide, afamelanotide (SCENESSE), treats erythropoietic protoporphyria and is not a tanning product.[2]
- A peptide tan offers no meaningful UV protection and can hide changing moles; Strong Health does not offer tanning peptides.
What are tanning peptides?
Tanning peptides are melanocortin peptides, synthetic analogs of alpha-melanocyte-stimulating hormone (α-MSH) that stimulate the skin to produce melanin. There are two very different things sold under this umbrella, and conflating them is dangerous:
- •Melanotan II: an unapproved, unregulated peptide widely sold online and via gray-market channels for cosmetic tanning. It is illegal to sell for human use in many countries and is not quality-controlled.
- •Afamelanotide (SCENESSE): a related, FDA-approved medication for a narrow, rare medical condition, administered by specialists.
How do melanocortin peptides work?
Melanocortin peptides work by activating the melanocortin-1 receptor (MC1R) on pigment cells, pushing them to produce more eumelanin, which darkens the skin. Melanin is your skin’s natural pigment and its built-in defense against UV damage. Some of these peptides also act on other melanocortin receptors, which is why side effects can extend well beyond pigmentation (for example, effects on appetite, arousal, and blood pressure).[1]
A peptide-induced tan does not make UV exposure safe, and stimulating pigment cells pharmacologically raises distinct concerns of its own.
What are the risks of Melanotan II?
The risks of Melanotan II include eruptive new moles and darkening of existing moles within 24 hours of a single dose, melanoma reported in users, and systemic effects such as nausea, flushing and blood-pressure changes. The products themselves are of unknown identity and sterility.[3][4] Melanotan II is the peptide most people mean by “tanning injections.” See our full Melanotan II molecule page for the detailed safety picture:
“Dermatologists should also be aware that these agents can complicate the clinical presentation of patients with pigmented lesions; their use may be suspected in unexpectedly tanned individuals with rapidly pigmenting naevi.”
| Option | Status | What it does | Documented risks |
|---|---|---|---|
| Melanotan II | Not approved; illegal to sell for human use in many countries | Activates MC1R and other melanocortin receptors; darkens skin | Eruptive and darkening moles, melanoma reports, nausea, flushing, blood-pressure changes, unregulated supply[1][3][4] |
| Afamelanotide (SCENESSE) | FDA-approved 2019 for erythropoietic protoporphyria | Implant that increases pain-free light exposure | Specialist use only; not for cosmetic tanning[2] |
| Sunless tanner (dihydroxyacetone lotion) | Cosmetic | Stains the outer skin layer | No UV protection; does not affect moles |
| Sunscreen, shade, clothing | Standard care | Prevents UV damage | None |
- •Changes in moles: eruptive new naevi and darkening of existing naevi were documented 24 hours after a single injection, and melanoma in situ has been reported in a Melanotan user.[3][4]
- •It is unregulated: products sold online have no guarantee of identity, purity, sterility, or dose, and are often self-injected.
- •Systemic side effects: nausea, facial flushing, spontaneous erections, and blood-pressure changes are commonly reported.
- •It provides no protection from UV damage and may encourage more sun or sunbed exposure.
Regulatory agencies including the U.S. FDA and the UK’s MHRA have warned against Melanotan products. For any concern about changing moles or skin lesions, see a dermatologist promptly.
What is afamelanotide, and why is it approved?
Afamelanotide (brand name SCENESSE) is an FDA-approved melanocortin medication, but not for cosmetic tanning. It is approved to increase pain-free light exposure in adults with erythropoietic protoporphyria (EPP), a rare inherited disorder that causes severe phototoxic pain, and it is administered by specialist clinicians as an implant.[2]
In other words, the one melanocortin peptide with regulatory approval is a specialist treatment for a rare disease, not a shortcut to a summer tan.
Does Strong Health offer tanning peptides?
We built our peptide practice on physician supervision, pharmacy-grade sourcing, and honest evidence. Cosmetic tanning peptides fail that standard. The safety concerns are real, the products are unregulated, and there is no version of “safe” self-injected Melanotan II we can stand behind.
If your underlying interest is skin health and appearance, we’re glad to help with approaches that have real support. See our guide to peptides for skin and anti-aging, or explore the physician-reviewed molecule library. And the most effective skin-protective habit remains daily sun protection.
Melanotan II is not an FDA-approved drug. It was one of the twelve peptides removed from the FDA’s Category 2 list in April 2026, which did not make it legal to compound or sell; as of late 2026 it is not on the 503A bulks list. This page is educational and is not medical advice or a dosing guide.
Frequently Asked Questions
Are tanning peptides safe?
Is Melanotan II FDA-approved?
Does a peptide tan protect me from the sun?
What is afamelanotide (SCENESSE)?
Does Strong Health offer tanning peptides?
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided has been reviewed by licensed healthcare professionals but individual results may vary.
Related Articles
Molecules in this guide
Browse the molecule library →Each peptide below has a physician-reviewed page covering what it is, the evidence, and how Strong Health prescribes it.
Peptide therapy near you
View all locations →Physician-supervised peptide therapy from our Miami (Brickell) clinic and via telehealth across 17 metros. Pick the location nearest you.
Have Questions About Skin & Safety?
Our physicians would rather talk you through skin health and real risks than sell you something unsafe. Book a consultation to discuss your goals honestly.
References & Citations
- Langan EA, Nie Z, Rhodes LE. Melanotropic peptides: more than just ‘Barbie drugs’ and ‘sun-tan jabs’? Br J Dermatol. 2010;163(3):451-455.
- U.S. Food and Drug Administration. FDA approves first treatment to increase pain-free light exposure in patients with a rare disorder (SCENESSE, afamelanotide). October 8, 2019.
- Schulze F, Erdmann H, Hardkop LH, et al. Eruptive naevi and darkening of pre-existing naevi 24 h after a single mono-dose injection of melanotan II. Eur J Dermatol. 2014;24(1):107-109.
- Ong S, Bowling J. Melanotan-associated melanoma in situ. Australas J Dermatol. 2012;53(4):301-302.